Fresenius Medical Care (NYSE:FMS) Shares Gap Down – Here’s Why

Fresenius Medical Care AG (NYSE:FMS)’s stock price gapped down prior to trading on Thursday . The stock had previously closed at $24.19, but opened at $23.35. Fresenius Medical Care shares last traded at $23.21, with a volume of 31,033 shares traded.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on FMS. StockNews.com raised Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 5th. Truist Financial raised their target price on Fresenius Medical Care from $23.00 to $25.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Finally, Bank of America raised Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a research report on Monday, December 2nd.

Fresenius Medical Care Stock Performance

The company has a 50-day moving average of $23.67 and a 200 day moving average of $22.17. The company has a quick ratio of 1.02, a current ratio of 1.37 and a debt-to-equity ratio of 0.42. The firm has a market capitalization of $14.10 billion, a PE ratio of 19.86, a PEG ratio of 0.76 and a beta of 0.99.

Hedge Funds Weigh In On Fresenius Medical Care

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Smartleaf Asset Management LLC grew its position in Fresenius Medical Care by 192.8% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company’s stock worth $28,000 after buying an additional 806 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new position in Fresenius Medical Care during the third quarter worth about $38,000. Russell Investments Group Ltd. grew its position in Fresenius Medical Care by 234.1% during the fourth quarter. Russell Investments Group Ltd. now owns 3,151 shares of the company’s stock worth $71,000 after buying an additional 2,208 shares in the last quarter. Jones Financial Companies Lllp lifted its stake in Fresenius Medical Care by 80.5% during the fourth quarter. Jones Financial Companies Lllp now owns 4,510 shares of the company’s stock worth $102,000 after purchasing an additional 2,012 shares during the last quarter. Finally, Venturi Wealth Management LLC lifted its stake in Fresenius Medical Care by 8.4% during the fourth quarter. Venturi Wealth Management LLC now owns 5,700 shares of the company’s stock worth $129,000 after purchasing an additional 441 shares during the last quarter. 8.37% of the stock is currently owned by hedge funds and other institutional investors.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.